Summary
4.01 -0.13(-3.14%)09/18/2024
PermRock Royalty Trust (PRT)
PermRock Royalty Trust (PRT)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
-3.14 | 3.35 | -2.20 | 5.80 | -7.82 | -41.12 | -34.10 | -60.75 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 4.01 | |
Open | 4.09 | |
High | 4.14 | |
Low | 4.01 | |
Volume | 21,125 | |
Change | -0.13 | |
Change % | -3.14 | |
Avg Volume (20 Days) | 46,877 | |
Volume/Avg Volume (20 Days) Ratio | 0.45 | |
52 Week Range | 3.58 - 6.99 | |
Price vs 52 Week High | -42.63% | |
Price vs 52 Week Low | 12.01% | |
Range | -1.96 | |
Gap Up/Down | -0.05 |
Fundamentals | ||
Market Capitalization (Mln) | 49 | |
EBIDTA | 0 | |
PE Ratio | 14.6269 | |
PEG Ratio | 0.0000 | |
WallStreet Target Price | 2.00 | |
Book Value | 7.0560 | |
Earnings Per Share | 0.4690 | |
EPS Estimate Current Quarter | 0.0000 | |
EPS Estimate Next Quarter | 0.0000 | |
EPS Estimate Current Year | 0.0000 | |
EPS Estimate Next Year | 0.0000 | |
Diluted EPS (TTM) | 0.4690 | |
Revenues | ||
Profit Marging | 0.8823 | |
Operating Marging (TTM) | 0.8823 | |
Return on asset (TTM) | 0.0406 | |
Return on equity (TTM) | 0.0652 | |
Revenue TTM | 6,464,161 | |
Revenue per share TTM | 0.5310 | |
Quarterly Revenue Growth (YOY) | 5.9510 | |
Quarterly Earnings Growth (YOY) | 16.2740 | |
Gross Profit (TTM) | 3,188,156 |
Dividends | ||
Dividend Share | 0.4690 | |
Dividend Yield | 0.0678 | |
Valuations | ||
Trailing PE | 14.6269 | |
Forward PE | 10.2775 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 0.9949 | |
Revenue Enterprise Value | 12.9628 | |
EBITDA Enterprise Value | 14.6917 | |
Shares | ||
Shares Outstanding | 12,165,700 | |
Shares Float | 12,156,973 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 0.07 | |
Institutions (%) | 48.75 |
09/13 10:00 EST - globenewswire.com
Prelude Therapeutics' SMARCA2 Degrader PRT3789 Demonstrated Promising Initial Clinical Activity and Safety Profile in Phase 1 Trial
- Encouraging signs of anti-tumor activity including objective responses observed in patients with SMARCA4-mutated non-small cell lung cancer (NSCLC) and esophageal cancer in early PRT3789 monotherapy dose escalation
Prelude Therapeutics' SMARCA2 Degrader PRT3789 Demonstrated Promising Initial Clinical Activity and Safety Profile in Phase 1 Trial
- Encouraging signs of anti-tumor activity including objective responses observed in patients with SMARCA4-mutated non-small cell lung cancer (NSCLC) and esophageal cancer in early PRT3789 monotherapy dose escalation
08/20 06:30 EST - prnewswire.com
PermRock Royalty Trust Declares Monthly Cash Distribution
DALLAS , Aug. 20, 2024 /PRNewswire/ -- PermRock Royalty Trust (NYSE:PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests in the Trust ("Trust Units") as of August 30, 2024, and payable on September 16, 2024, in the amount of $488,593.20 ($0.040161 per Trust Unit), based principally upon production during the month of June 2024. The following table displays underlying oil and natural gas sales volumes and average received wellhead prices attributable to the current and prior month net profits interest calculations: Underlying Sales Volumes Average Price Oil Natural Gas Oil Natural Gas Bbls Bbls/D Mcf Mcf/D (per Bbl) (per Mcf) Current Month 22,761 759 30,104 1,003 $76.91 $2.09 Prior Month 24,389 787 30,833 995 $78.30 $1.88 Oil cash receipts for the properties underlying the Trust totaled $1.75 million for the current month, a decrease of $0.16 million from the prior month's distribution period.
PermRock Royalty Trust Declares Monthly Cash Distribution
DALLAS , Aug. 20, 2024 /PRNewswire/ -- PermRock Royalty Trust (NYSE:PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests in the Trust ("Trust Units") as of August 30, 2024, and payable on September 16, 2024, in the amount of $488,593.20 ($0.040161 per Trust Unit), based principally upon production during the month of June 2024. The following table displays underlying oil and natural gas sales volumes and average received wellhead prices attributable to the current and prior month net profits interest calculations: Underlying Sales Volumes Average Price Oil Natural Gas Oil Natural Gas Bbls Bbls/D Mcf Mcf/D (per Bbl) (per Mcf) Current Month 22,761 759 30,104 1,003 $76.91 $2.09 Prior Month 24,389 787 30,833 995 $78.30 $1.88 Oil cash receipts for the properties underlying the Trust totaled $1.75 million for the current month, a decrease of $0.16 million from the prior month's distribution period.
07/09 07:30 EST - globenewswire.com
Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers
Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor activity of either agent because of the complementary nature of the two mechanisms .
Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers
Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor activity of either agent because of the complementary nature of the two mechanisms .
12/27 08:52 EST - 247wallst.com
6 Dividend Stocks I Wouldn't Touch With a 10 Foot Pole
The company owns a 75% net overriding royalty interest in the Waddell Ranch properties comprising Dune, Sand Hills (Judkins) Sand Hills (McKnight) Sand Hills (Tubb) University-Waddell (Devonian) Waddell Fields is located in Crane County, Texas.
6 Dividend Stocks I Wouldn't Touch With a 10 Foot Pole
The company owns a 75% net overriding royalty interest in the Waddell Ranch properties comprising Dune, Sand Hills (Judkins) Sand Hills (McKnight) Sand Hills (Tubb) University-Waddell (Devonian) Waddell Fields is located in Crane County, Texas.
07/17 13:47 EST - seekingalpha.com
87 Monthly Paying Dividend Stocks And 80 Funds For July
Imagine stocks or funds that pay out their dividends once-a-month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These July U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and net-gains include: 1. Stocks by-yield (87); 2. Stocks by price-upside (30); 3. Closed-End-Investments, Exchange-Traded-Funds & Notes (CEICs/ETFs/ETNs) by-yield >8.74% (80). Items: 1. Top MoPay stock gains; 2. Overall best MoPay gainers; 3. Funds vs.Equities; 4. Fund risks/rewards. All per prices as of 7/13/23.
87 Monthly Paying Dividend Stocks And 80 Funds For July
Imagine stocks or funds that pay out their dividends once-a-month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These July U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and net-gains include: 1. Stocks by-yield (87); 2. Stocks by price-upside (30); 3. Closed-End-Investments, Exchange-Traded-Funds & Notes (CEICs/ETFs/ETNs) by-yield >8.74% (80). Items: 1. Top MoPay stock gains; 2. Overall best MoPay gainers; 3. Funds vs.Equities; 4. Fund risks/rewards. All per prices as of 7/13/23.
04/13 17:01 EST - investorplace.com
7 Blue-Chip Stocks That Pay You Monthly Dividends
Generally speaking, investing in blue-chip stocks that pay monthly dividends has several advantages. The most obvious advantage, and one that's particularly attractive currently, is income.
7 Blue-Chip Stocks That Pay You Monthly Dividends
Generally speaking, investing in blue-chip stocks that pay monthly dividends has several advantages. The most obvious advantage, and one that's particularly attractive currently, is income.
03/27 15:54 EST - investorplace.com
7 Monthly Dividend Stocks to Buy During the Market Jitters
With banking sector fears once again dominating headlines, investors should consider the consistent passive income potential of monthly dividend stocks to buy. Typically, companies that provide passive income do so on a quarterly basis.
7 Monthly Dividend Stocks to Buy During the Market Jitters
With banking sector fears once again dominating headlines, investors should consider the consistent passive income potential of monthly dividend stocks to buy. Typically, companies that provide passive income do so on a quarterly basis.